Eosinophilic Esophagitis (EoE) is a chronic, immune-mediated disorder. EoE symptoms can overlap with symptoms of a condition called gastroesophageal reflux disease (GERD).

Patients with EoE experience symptoms described as:

• feeling like food or liquid is moving slowly
• feeling food or liquid going down
• food getting stuck in the esophagus
• acid reflux, chest pain, nausea, vomiting
• failure to thrive (children), regurgitation and esophageal strictures.

It occurs in approximately 1 in 10,000 people and affects people of all age groups, with males being affected more frequently. EOE is associated with food allergies or other allergens, causing eosinophils (type of white blood cell) to migrate from the bone marrow (via blood) and settle in the esophagus causing inflammation to the esophagus. No one knows exactly why EoE occurs.  People with EoE tend to have allergic conditions such asthma, seasonal allergies, allergic rhinitis, and eczema.

We are conducting a clinical trial for people with Eosinophilic Esophagitis. The purpose of this study is to assess the safety and tolerability of a new oral investigational medication for Eosinophilic Esophagitis.

Volunteers may be eligible if they:

• Are aged 18 or older.
• Have a diagnosis or presumed diagnosis of EOE which will be confirmed during the screening process.

There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study related investigational medication, procedures and medical exams at no cost, as well as reimbursement for time and travel. No health insurance is required to participate.

For more information call